Chemical Diagnostics | Immunoassays | PETIA | Assays
medical, diagnostics, immunoassays, assays, in vitro diagnostics, IVD products, avian antibodies, antibodies, clinical chemistry, diagnostic tests, biotechnology
page-template,page-template-full_width,page-template-full_width-php,page,page-id-16116,page-child,parent-pageid-15948,bridge-core-1.0.6,ajax_fade,page_not_loaded,,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.2,qode-theme-bridge,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

Our People

Unique Innovation

Our people convert knowledge and research into products that improve diagnostic efficiency.


At Gentian we combine interdisciplinarity and experience with scientific knowledge. The Gentian team is highly international and has experience from global in vitro diagnostic companies. As a result, we offer improved solutions, improved clinical accuracy and diagnostic efficiencies.

Highly qualified and international team within anti body and nano-technology

Excellent skills, broad experience, motivation, creativity and hard work is our key to success. Competence from different areas covering R&D, Sales, Marketing, Finance and TQM provides a perfect basis to reach our goals.

Gentian employees in the lab

Our Management

Hilja Ibert


Hilja Ibert has over 25 years’ experience from the international diagnostic industry, from which she has an extensive leadership experience. Dr. Ibert has previously held the position as VP International Diagnostic Solutions at Hologic, and several senior positions within Becton Dickinson and bioMerieux. Dr. Ibert also has experience with early stage R&D companies, like her position as CEO for miDiagnostics in Belgium.

Dr. Ibert holds a PhD degree in Nutrition Science from the University of Bonn, Germany.

Erling Sundrehagen


Erling Sundrehagen holds 25 international patents. He has over the years headed the development of a dozen diagnostic products creating businesses with 1250 employees. From 1984 to 2013 he was the Head of Scientific Projects in Axis-Shield, comprising 3 consortium project in EU framework programs. Dr. Sundrehagen has held several management positions in Axis-Shield pls, Axis Biochemicals AS and Axis Research AS.

Dr. Sundrehagen is cand.real (Dr. Med. Sci., M. Sc.) from University of Oslo, Norway.

Njaal Kind


Njaal Kind has more than 20 years of experience and extended track-record within financial management and reporting, corporate governance and Investor Relation. Kind has served as the CFO for TiZir Ltd in London, England from 2013-2017. Before that, Mr. Kind has been Business Analyst in Eramet Comilog Manganese in Paris, France (2009-2013) and Investment Director in Tinfos AS in Oslo, Norway (2003-2009).

Kind holds a MSc from BI Norwegian Business School

Bård Sundrehagen

Executive Vice President BD

Bård Sundrehagen has for over 25 years worked in different positions in Norwegian medical diagnostics companies. As one of the co-founders of Gentian, he incorporated the first companies in the Gentian Diagnostics family in 2000.  Since then Sundrehagen has been the CEO of the group until recently. He also has 6 years’ experience from Alcatel in the telecom industry.

Sundrehagen holds a BSc in Economics from the University in Oslo, Norway and a business degree from BI Norwegian Business School.